iSpecimen Ownership 2024 | Who Owns iSpecimen Now?
Institutional Ownership
3.31%
Insider Ownership
21.36%
Retail Ownership
75.33%
Institutional Holders
11.00
iSpecimen Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VANGUARD GROUP INC | 0.85% | - | 76,557 | -57,544 | -42.91% | 17,761 | Mar 31, 2024 |
BLACKROCK INC. | 0.63% | - | 56,538 | -161 | -0.28% | 13,117 | Mar 31, 2024 |
MILLENNIUM MANAGEMENT LLC | 0.49% | - | 44,057 | 22,569 | 105.03% | 10,221 | Mar 31, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.43% | - | 38,498 | - | - | 8,931 | Mar 31, 2024 |
GRIMES & COMPANY, INC. | 0.34% | 0.00% | 30,818 | - | - | 7,150 | Mar 31, 2024 |
SCHONFELD STRATEGIC ADVISORS LLC | 0.17% | - | 15,200 | -2,300 | -13.14% | 3,526 | Mar 31, 2024 |
NORTHERN TRUST CORP | 0.15% | - | 13,805 | - | - | 3,203 | Mar 31, 2024 |
MAIN STREET FINANCIAL SOLUTIONS, LLC | 0.12% | 0.00% | 10,500 | - | - | 2,436 | Mar 31, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.11% | - | 10,000 | -692 | -6.47% | 2,000 | Mar 31, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | - | 3,186 | 115 | 3.74% | 739 | Mar 31, 2024 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 42 | 1 | 2.44% | 10,000 | Mar 31, 2024 |
CITADEL ADVISORS LLC | - | - | - | -38,809 | -100.00% | - | Mar 31, 2024 |
UBS GROUP AG | - | - | - | -13 | -100.00% | - | Mar 31, 2024 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -15,516 | -100.00% | - | Mar 31, 2024 |
iSpecimen's largest institutional shareholder is VANGUARD GROUP INC, holding 0.85% of the company's total share outstanding, currently valued at $17.76K. The top 10 institutional shareholders own together 3.31% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MAIN STREET FINANCIAL SOLUTIONS, LLC | 0.12% | 0.00% | 10,500 | - | - | 2,436 | Mar 31, 2024 |
GRIMES & COMPANY, INC. | 0.34% | 0.00% | 30,818 | - | - | 7,150 | Mar 31, 2024 |
SCHONFELD STRATEGIC ADVISORS LLC | 0.17% | - | 15,200 | -2,300 | -13.14% | 3,526 | Mar 31, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | - | 3,186 | 115 | 3.74% | 739 | Mar 31, 2024 |
MILLENNIUM MANAGEMENT LLC | 0.49% | - | 44,057 | 22,569 | 105.03% | 10,221 | Mar 31, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.11% | - | 10,000 | -692 | -6.47% | 2,000 | Mar 31, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.43% | - | 38,498 | - | - | 8,931 | Mar 31, 2024 |
NORTHERN TRUST CORP | 0.15% | - | 13,805 | - | - | 3,203 | Mar 31, 2024 |
VANGUARD GROUP INC | 0.85% | - | 76,557 | -57,544 | -42.91% | 17,761 | Mar 31, 2024 |
BLACKROCK INC. | 0.63% | - | 56,538 | -161 | -0.28% | 13,117 | Mar 31, 2024 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 42 | 1 | 2.44% | 10,000 | Mar 31, 2024 |
CITADEL ADVISORS LLC | - | - | - | -38,809 | -100.00% | - | Mar 31, 2024 |
UBS GROUP AG | - | - | - | -13 | -100.00% | - | Mar 31, 2024 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -15,516 | -100.00% | - | Mar 31, 2024 |
The largest iSpecimen shareholder by % of total assets is MAIN STREET FINANCIAL SOLUTIONS, LLC. The company owns 10.50K shares of iSpecimen (ISPC), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MILLENNIUM MANAGEMENT LLC | 0.49% | - | 44,057 | 22,569 | 105.03% | 10,221 | Mar 31, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | - | 3,186 | 115 | 3.74% | 739 | Mar 31, 2024 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 42 | 1 | 2.44% | 10,000 | Mar 31, 2024 |
NORTHERN TRUST CORP | 0.15% | - | 13,805 | - | - | 3,203 | Mar 31, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.43% | - | 38,498 | - | - | 8,931 | Mar 31, 2024 |
GRIMES & COMPANY, INC. | 0.34% | 0.00% | 30,818 | - | - | 7,150 | Mar 31, 2024 |
MAIN STREET FINANCIAL SOLUTIONS, LLC | 0.12% | 0.00% | 10,500 | - | - | 2,436 | Mar 31, 2024 |
UBS GROUP AG | - | - | - | -13 | -100.00% | - | Mar 31, 2024 |
BLACKROCK INC. | 0.63% | - | 56,538 | -161 | -0.28% | 13,117 | Mar 31, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.11% | - | 10,000 | -692 | -6.47% | 2,000 | Mar 31, 2024 |
SCHONFELD STRATEGIC ADVISORS LLC | 0.17% | - | 15,200 | -2,300 | -13.14% | 3,526 | Mar 31, 2024 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -15,516 | -100.00% | - | Mar 31, 2024 |
CITADEL ADVISORS LLC | - | - | - | -38,809 | -100.00% | - | Mar 31, 2024 |
VANGUARD GROUP INC | 0.85% | - | 76,557 | -57,544 | -42.91% | 17,761 | Mar 31, 2024 |
As of Mar 31 2024, iSpecimen's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 22.57K stocks of ISPC, valued at $10.22K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VANGUARD GROUP INC | 0.85% | - | 76,557 | -57,544 | -42.91% | 17,761 | Mar 31, 2024 |
CITADEL ADVISORS LLC | - | - | - | -38,809 | -100.00% | - | Mar 31, 2024 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -15,516 | -100.00% | - | Mar 31, 2024 |
SCHONFELD STRATEGIC ADVISORS LLC | 0.17% | - | 15,200 | -2,300 | -13.14% | 3,526 | Mar 31, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.11% | - | 10,000 | -692 | -6.47% | 2,000 | Mar 31, 2024 |
BLACKROCK INC. | 0.63% | - | 56,538 | -161 | -0.28% | 13,117 | Mar 31, 2024 |
UBS GROUP AG | - | - | - | -13 | -100.00% | - | Mar 31, 2024 |
MAIN STREET FINANCIAL SOLUTIONS, LLC | 0.12% | 0.00% | 10,500 | - | - | 2,436 | Mar 31, 2024 |
GRIMES & COMPANY, INC. | 0.34% | 0.00% | 30,818 | - | - | 7,150 | Mar 31, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.43% | - | 38,498 | - | - | 8,931 | Mar 31, 2024 |
NORTHERN TRUST CORP | 0.15% | - | 13,805 | - | - | 3,203 | Mar 31, 2024 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 42 | 1 | 2.44% | 10,000 | Mar 31, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | - | 3,186 | 115 | 3.74% | 739 | Mar 31, 2024 |
MILLENNIUM MANAGEMENT LLC | 0.49% | - | 44,057 | 22,569 | 105.03% | 10,221 | Mar 31, 2024 |
As of Mar 31 2024, iSpecimen's biggest institutional seller is VANGUARD GROUP INC. The company sold -57.54K shares of ISPC, valued at $17.76K.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CITADEL ADVISORS LLC | - | - | - | -38,809 | -100.00% | - | Mar 31, 2024 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -15,516 | -100.00% | - | Mar 31, 2024 |
UBS GROUP AG | - | - | - | -13 | -100.00% | - | Mar 31, 2024 |
iSpecimen's largest sold out institutional shareholder by shares sold is CITADEL ADVISORS LLC, sold -38.81K shares, valued at -, as of undefined.
iSpecimen Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
TETON WESTWOOD FUNDS | 0.06% | 38,000 | - | - | Dec 29, 2023 |
VANGUARD INDEX FUNDS | 0.00% | 170,752 | 20,152 | 13.38% | Dec 31, 2023 |
FIDELITY CONCORD STREET TRUST | 0.00% | 38,498 | - | - | Feb 29, 2024 |
EQ ADVISORS TRUST | 0.00% | 1,307 | - | - | Dec 31, 2023 |
iSHARES TRUST | 0.00% | 13,169 | - | - | Feb 29, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 803 | - | - | Dec 31, 2023 |
iSpecimen's largest mutual fund holder by % of total assets is "TETON WESTWOOD FUNDS", owning 38.00K shares, compromising 0.06% of its total assets.
iSpecimen Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 24 | 11 | -21.43% |
31 Dec, 23 | 14 | 16.67% |
30 Sep, 23 | 12 | -7.69% |
30 Jun, 23 | 13 | - |
31 Mar, 23 | 13 | - |
31 Dec, 22 | 13 | - |
30 Sep, 22 | 13 | - |
30 Jun, 22 | 13 | 8.33% |
31 Mar, 22 | 12 | 20.00% |
31 Dec, 21 | 10 | 25.00% |
30 Sep, 21 | 8 | 33.33% |
30 Jun, 21 | 6 | - |
As of 31 Mar 24, 11 institutions are holding iSpecimen's shares, representing a decrease of -21.43% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 24 | 299,201 | -23.59% |
31 Dec, 23 | 391,551 | 8.03% |
30 Sep, 23 | 362,436 | -13.21% |
30 Jun, 23 | 417,609 | -13.61% |
31 Mar, 23 | 483,415 | 1.65% |
31 Dec, 22 | 475,551 | 0.54% |
30 Sep, 22 | 472,996 | 26.87% |
30 Jun, 22 | 372,806 | 19.97% |
31 Mar, 22 | 310,739 | -73.21% |
31 Dec, 21 | 1,159,956 | 26.59% |
30 Sep, 21 | 916,326 | -17.41% |
30 Jun, 21 | 1,109,522 | - |
iSpecimen (ISPC) has 299.20K shares outstanding as of 31 Mar 24, down -23.59% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 24 | 3.31% | 17.74% |
31 Dec, 23 | 4.32% | 26.83% |
30 Sep, 23 | 4.01% | 18.55% |
30 Jun, 23 | 4.65% | 16.05% |
31 Mar, 23 | 5.38% | 18.62% |
31 Dec, 22 | 5.38% | 18.95% |
30 Sep, 22 | 5.33% | 29.83% |
30 Jun, 22 | 4.23% | 33.63% |
31 Mar, 22 | 3.54% | 1.28% |
31 Dec, 21 | 16.67% | 9.62% |
30 Sep, 21 | 13.16% | 5.18% |
30 Jun, 21 | 15.94% | - |
As of 31 Mar 24, iSpecimen is held by 3.31% institutional shareholders, representing a 17.74% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 24 | 3 | -40.00% |
31 Dec, 23 | 5 | - |
30 Sep, 23 | 5 | 66.67% |
30 Jun, 23 | 3 | 50.00% |
31 Mar, 23 | 2 | -50.00% |
31 Dec, 22 | 4 | -33.33% |
30 Sep, 22 | 6 | -25.00% |
30 Jun, 22 | 8 | -20.00% |
31 Mar, 22 | 10 | 25.00% |
31 Dec, 21 | 8 | 14.29% |
30 Sep, 21 | 7 | 16.67% |
30 Jun, 21 | 6 | - |
3 institutional shareholders have increased their position in ISPC stock as of 31 Mar 24 compared to 5 in the previous quarter (a -40.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 24 | 4 | -20.00% |
31 Dec, 23 | 5 | 25.00% |
30 Sep, 23 | 4 | 300.00% |
30 Jun, 23 | 1 | -80.00% |
31 Mar, 23 | 5 | 150.00% |
31 Dec, 22 | 2 | -33.33% |
30 Sep, 22 | 3 | 50.00% |
30 Jun, 22 | 2 | - |
31 Mar, 22 | 2 | - |
31 Dec, 21 | 2 | - |
30 Sep, 21 | - | - |
30 Jun, 21 | - | - |
4 institutional shareholders have reduced their position in ISPC stock as of 31 Mar 24 compared to 5 in the previous quarter (a -20.00% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 24 | 11 | -21.43% | 299,201 | -23.59% | 3.31% | 17.74% | 3 | -40.00% | 4 | -20.00% |
31 Dec, 23 | 14 | 16.67% | 391,551 | 8.03% | 4.32% | 26.83% | 5 | - | 5 | 25.00% |
30 Sep, 23 | 12 | -7.69% | 362,436 | -13.21% | 4.01% | 18.55% | 5 | 66.67% | 4 | 300.00% |
30 Jun, 23 | 13 | - | 417,609 | -13.61% | 4.65% | 16.05% | 3 | 50.00% | 1 | -80.00% |
31 Mar, 23 | 13 | - | 483,415 | 1.65% | 5.38% | 18.62% | 2 | -50.00% | 5 | 150.00% |
31 Dec, 22 | 13 | - | 475,551 | 0.54% | 5.38% | 18.95% | 4 | -33.33% | 2 | -33.33% |
30 Sep, 22 | 13 | - | 472,996 | 26.87% | 5.33% | 29.83% | 6 | -25.00% | 3 | 50.00% |
30 Jun, 22 | 13 | 8.33% | 372,806 | 19.97% | 4.23% | 33.63% | 8 | -20.00% | 2 | - |
31 Mar, 22 | 12 | 20.00% | 310,739 | -73.21% | 3.54% | 1.28% | 10 | 25.00% | 2 | - |
31 Dec, 21 | 10 | 25.00% | 1,159,956 | 26.59% | 16.67% | 9.62% | 8 | 14.29% | 2 | - |
30 Sep, 21 | 8 | 33.33% | 916,326 | -17.41% | 13.16% | 5.18% | 7 | 16.67% | - | - |
30 Jun, 21 | 6 | - | 1,109,522 | - | 15.94% | - | 6 | - | - | - |
iSpecimen Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of iSpecimen's stock was made by Ianelli Christopher on Jan 19 2023, selling 845 shares at - per share (valued at -). The last insider buy of ISPC was made by Bielak Benjamin on Sep 15 2023, buying 18,000 shares at $0.72 per share (worth $12.96K).
iSpecimen Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2023 | 1 | - | - |
Q2 2023 | 1 | - | - |
Q1 2023 | 15 | 2 | 750.00% |
Q4 2022 | 2 | 5 | 40.00% |
Q2 2022 | - | 4 | - |
Q1 2022 | 4 | 4 | 100.00% |
Q4 2021 | 7 | - | - |
Q3 2021 | 6 | - | - |
Q2 2021 | 19 | 28 | 67.86% |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by iSpecimen's insiders, as of Q3 2023.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2023 | 1 | - | - |
Q2 2023 | 1 | - | - |
Q1 2023 | - | - | - |
Q4 2022 | - | - | - |
Q2 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | 7 | - | - |
Q3 2021 | - | - | - |
Q2 2021 | 2 | - | - |
As of Q3 2023, Insider owners conducted 1 open market buy trades and 0 open market sell trades of iSpecimen's stocks.
iSpecimen Peer Ownership
Ticker | Company |
---|---|
INBS | Intelligent Bio Solutions Inc. |
FONR | FONAR Corporation |
GTH | Genetron Holdings Limited |
XGN | Exagen Inc. |
PSNL | Personalis, Inc. |
HTGM | HTG Molecular Diagnostics, Inc. |
BIOC | Biocept, Inc. |
OCX | OncoCyte Corporation |
CSTL | Castle Biosciences, Inc. |
SQL | SeqLL Inc. |
TTOO | T2 Biosystems, Inc. |
TRIB | Trinity Biotech plc |
OLK | Olink Holding AB (publ) |
ISPC Ownership FAQ
Who Owns iSpecimen?
iSpecimen is owned by institutional shareholders (3.31%), insiders (21.36%), and public (75.33%). The largest institutional shareholder of iSpecimen is VANGUARD GROUP INC (0.85% of total shares) and the top mutual fund owner is TETON WESTWOOD FUNDS (0.06% of total shares).
Who are the major institutional shareholders of iSpecimen?
iSpecimen's major institutional shareholders are VANGUARD GROUP INC, BLACKROCK INC., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and GRIMES & COMPANY, INC.. The top five shareholders own together 2.73% of the company's share outstanding.
How many iSpecimen shareholders are there?
As of Mar 2024, there are 11 institutional shareholders of iSpecimen.
What percentage of iSpecimen is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 76.56K shares of iSpecimen, representing 0.85% of the company's total shares outstanding, valued at $17.76K (as of Mar 2024).
What percentage of iSpecimen is owned by BLACKROCK INC?
As of Mar 2024, BLACKROCK INC holds 56.54K shares of iSpecimen (ISPC), compromising 0.63% of the company, valued at $13.12K.
What percentage of iSpecimen is owned by MILLENNIUM MANAGEMENT LLC?
MILLENNIUM MANAGEMENT LLC is the third largest holder of iSpecimen. The company owns 44.06K of the company's shares outstanding (worth $10.22K).